Chris Grace
Papers
1
Total Citations
127
H-Index
1
About
Chris Grace is a leading figure in translational bioanalytical chemistry, with a primary focus on developing cutting-edge mass spectrometry-based methods for quantifying protein biomarkers in complex biological matrices. His most cited work, a 2012 paper with 127 citations, exemplifies his major contribution: pioneering sequential protein and peptide immunoaffinity capture techniques. This approach dramatically enhances the sensitivity and specificity of mass spectrometry, enabling the precise quantification of low-abundance proteins like human β-Nerve Growth Factor (NGF). This work was directly instrumental in supporting the clinical development of tanezumab, a monoclonal antibody therapy for chronic pain, by providing a robust method to measure drug-target engagement. Grace’s impact lies in bridging the gap between advanced analytical chemistry and real-world drug development, providing the quantitative tools necessary to validate therapeutic mechanisms. His research has been essential for pharmacokinetic and pharmacodynamic studies, solidifying his reputation as a key innovator in bioanalysis who empowers the translation of novel biologics from bench to bedside.
Research Focus
Key Achievements
Top Papers
- 1